I am a
Home I AM A Search Login

Papers of the Week


2022


Biomed Res Int


2022

Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial.

Authors

Zhang J, Liu DY, Gong Q, Chen J, Wan L
Biomed Res Int. 2022; 2022:9563693.
PMID: 36262971.

Abstract

Platelet-rich plasma (PRP) contains high concentrations of growth factors and cytokines and may promote healing and tissue formation and exert anti-inflammatory effects. PRP has been shown to improve intervertebral disc degeneration in vivo and in vitro. This study is aimed at evaluating the effectiveness of autologous PRP on discogenic low back pain (DLBP) at 48 weeks postinjection in patients who received a single intradiscal injection.